Puma Biotechnology Inc (PBYI): Price and Financial Metrics
GET POWR RATINGS... FREE!
PBYI POWR Grades
- Value is the dimension where PBYI ranks best; there it ranks ahead of 94.83% of US stocks.
- PBYI's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
- PBYI ranks lowest in Momentum; there it ranks in the 9th percentile.
PBYI Stock Summary
- Puma Biotechnology Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 96.3% of US listed stocks.
- The price/operating cash flow metric for Puma Biotechnology Inc is higher than 76.19% of stocks in our set with a positive cash flow.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 25.94 for Puma Biotechnology Inc; that's greater than it is for 98.37% of US stocks.
- Stocks that are quantitatively similar to PBYI, based on their financial statements, market capitalization, and price volatility, are QTWO, MANH, NSTG, AERI, and LPSN.
- Visit PBYI's SEC page to see the company's official filings. To visit the company's web site, go to www.pumabiotechnology.com.
PBYI Valuation Summary
- PBYI's EV/EBIT ratio is -16.1; this is 154.95% lower than that of the median Healthcare stock.
- Over the past 114 months, PBYI's EV/EBIT ratio has gone up 6.
- PBYI's price/sales ratio has moved NA NA over the prior 114 months.
Below are key valuation metrics over time for PBYI.
PBYI Growth Metrics
- The 4 year cash and equivalents growth rate now stands at 11.76%.
- The 2 year revenue growth rate now stands at 138.22%.
- Its year over year price growth rate is now at -2.02%.
The table below shows PBYI's growth in key financial areas (numbers in millions of US dollars).
|Date||Revenue||Operating Cash Flow||Net Income to Common Stock|
PBYI's Quality FactorsThe “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
- PBYI has a Quality Grade of C, ranking ahead of 65.48% of graded US stocks.
- PBYI's asset turnover comes in at 0.995 -- ranking 23rd of 677 Pharmaceutical Products stocks.
- SRNE, VBLT, and XOMA are the stocks whose asset turnover ratios are most correlated with PBYI.
The table below shows PBYI's key quality metrics over time.
|Period||Asset Turnover||Gross Margin||ROIC|
PBYI Stock Price Chart Interactive Chart >
PBYI Price/Volume Stats
|Current price||$7.30||52-week high||$14.14|
|Prev. close||$7.12||52-week low||$6.48|
|Day high||$7.73||Avg. volume||371,823|
|50-day MA||$7.29||Dividend yield||N/A|
|200-day MA||$9.69||Market Cap||297.69M|
Puma Biotechnology Inc (PBYI) Company Bio
Puma Biotechnology is a development stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of products for the treatment of various forms of cancer. The company was founded in 2010 and is based in Los Angeles, California.
Most Popular Stories View All
PBYI Latest News Stream
|Loading, please wait...|
PBYI Latest Social Stream
View Full PBYI Social Stream
Latest PBYI News From Around the Web
Below are the latest news stories about Puma Biotechnology Inc that investors may wish to consider to help them evaluate PBYI as an investment opportunity.
LOS ANGELES, September 21, 2021--Alan Auerbach will present an overview of Puma Biotechnology at 8:00 a.m. EDT on Sept. 28, at the 2021 Cantor Virtual Global Healthcare Conference.
LOS ANGELES--(BUSINESS WIRE)--On Sept. 7, 2021, Puma Biotechnology reported inducement awards granted to new staff in August, as required by Nasdaq Listing Rule 5635(c)(4) .
LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach will present an overview of Puma Biotechnology at the H.C. Wainwright 23rd Annual Global Investment Conference beginning on Sept. 13.
Puma Biotech (PBYI) reports better-than-expected Q2 earnings and sales. It lowers 2021 Nerlynx sales guidance.
Puma Biotech (PBYI) delivered earnings and revenue surprises of 58.06% and 4.69%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
PBYI Price Returns
Continue Researching PBYIWant to do more research on Puma Biotechnology Inc's stock and its price? Try the links below:
Puma Biotechnology Inc (PBYI) Stock Price | Nasdaq
Puma Biotechnology Inc (PBYI) Stock Quote, History and News - Yahoo Finance
Puma Biotechnology Inc (PBYI) Stock Price and Basic Information | MarketWatch